Imugene (Australia) Price on September 19, 2024
| IMU Stock | 0.04 0 5.13% |
Below is the normalized historical share price chart for Imugene extending back to December 31, 1993. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Imugene stands at 0.04, as last reported on the 18th of December 2024, with the highest price reaching 0.04 and the lowest price hitting 0.04 during the day.
If you're considering investing in Imugene Stock, it is important to understand the factors that can impact its price. Imugene holds Efficiency (Sharpe) Ratio of -0.12, which attests that the entity had a -0.12% return per unit of risk over the last 3 months. Imugene exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Imugene's Standard Deviation of 3.94, market risk adjusted performance of (0.96), and Risk Adjusted Performance of (0.06) to validate the risk estimate we provide.
At this time, Imugene's Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Total Equity is likely to gain to about 126.7 M in 2024, despite the fact that Sale Purchase Of Stock is likely to grow to (2.6 M). . Imugene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.0614 | 50 Day MA 0.0436 | Beta 3.34 |
Imugene |
Sharpe Ratio = -0.1176
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IMU |
Estimated Market Risk
| 3.88 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.46 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Imugene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Imugene by adding Imugene to a well-diversified portfolio.
Price Book 2.3676 | Book Value 0.016 | Enterprise Value 188.4 M | Enterprise Value Ebitda (15.51) | Price Sales 57.8566 |
Imugene Main Headline on 19th of September 2024
Just the Facts Imugene receives Orphan Drug Designation for ... by news.google.com
Just the Facts Imugene receives Orphan Drug Designation for VAXINIA from FDA Proactive Investors USA
Imugene Valuation on September 19, 2024
It is possible to determine the worth of Imugene on a given historical date. On September 19, 2024 Imugene was worth 0.052 at the beginning of the trading date compared to the closed value of 0.052. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Imugene stock. Still, in general, we apply an absolute valuation method to find Imugene's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Imugene where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Imugene's related companies.
| Open | High | Low | Close | Volume | |
| 0.05 | 0.06 | 0.05 | 0.05 | 80,117,069 | |
09/19/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 20,836,591 |
| 0.05 | 0.05 | 0.05 | 0.05 | 57,583,709 |
| Backtest Imugene | | | Imugene History | | | Imugene Valuation | Previous | Next |
Imugene Trading Date Momentum on September 19, 2024
| On September 20 2024 Imugene was traded for 0.05 at the closing time. The maximum traded price for the trading interval was 0.05 and the lowest daily price was 0.05 . The daily volume was recorded at 57.6 M. The volume of trading on 20th of September 2024 played a part in the next trading day price drop. The trading delta at closing time to the next closing price was 7.69% . The trading delta at closing time to the closing price today is 7.69% . |
Imugene Fundamentals Correlations and Trends
By evaluating Imugene's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Imugene's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Imugene financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Imugene Stock history
Imugene investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Imugene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Imugene will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Imugene stock prices may prove useful in developing a viable investing in Imugene
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 7.1 B | 7.4 B | |
| Net Loss | -34.1 M | -32.4 M |
Imugene Quarterly Net Working Capital |
|
Imugene Stock Technical Analysis
Imugene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Imugene Period Price Range
Low | December 18, 2024
| High |
0.00 | 0.00 |
Imugene cannot be verified against its exchange. Please verify the symbol is currently traded on Australian Securities Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Imugene December 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Imugene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Imugene shares will generate the highest return on investment. By undertsting and applying Imugene stock market strength indicators, traders can identify Imugene entry and exit signals to maximize returns
Imugene Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Imugene's price direction in advance. Along with the technical and fundamental analysis of Imugene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Imugene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (0.97) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Imugene Stock Analysis
When running Imugene's price analysis, check to measure Imugene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imugene is operating at the current time. Most of Imugene's value examination focuses on studying past and present price action to predict the probability of Imugene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imugene's price. Additionally, you may evaluate how the addition of Imugene to your portfolios can decrease your overall portfolio volatility.